These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4632451)

  • 1. Interaction of platelets with ascitic plasmacytoma in vitro.
    Pedio G; Rüttner JR; Odermatt B
    Acta Haematol; 1973; 49(1):48-56. PubMed ID: 4632451
    [No Abstract]   [Full Text] [Related]  

  • 2. The serum paraprotein level related to the number of plasmacytoma-5536 cells in C3H mice.
    Fakhri O; Hobbs JR
    Br J Cancer; 1970 Jun; 24(2):395-7. PubMed ID: 5451577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombopenia in experimental HIPA plasmacytoma in the BALB-c mouse].
    Schweyer H; Rüttner JR; Pedio G
    Acta Haematol; 1970; 44(5):305-19. PubMed ID: 4994893
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncogenic viruses in the thrombocytopenic stage of experimental HIPA-plasmacytoma.
    Pedio G; Rüttner JR; Odermatt B; Gut D
    Experientia; 1974 Mar; 30(3):289-91. PubMed ID: 4363226
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A methodological contribution on the function testing of human blood platelets under standard conditions].
    Gross R; Niemeyer G; Reuter H
    Dtsch Med Wochenschr; 1969 Aug; 94(35):1735-43. PubMed ID: 4980283
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophoretic changes of serum and virus particles type 'C' and 'A' in a plasmyocytoma of Balb-c mice.
    Pedio G; Rüttner JR
    Experientia; 1971 Aug; 27(8):949-51. PubMed ID: 5004465
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor XIII deficiency in BALB/c mice with plasmacytoma.
    Eipe J; Yakulis V; Costea N
    Cancer Res; 1977 Oct; 37(10):3551-5. PubMed ID: 908006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
    Patel M; Havas HF
    Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against MOPC-315 plasmacytoma by immunization with C-type particle preparations.
    Kleinman R; Dray S
    Cancer Res; 1978 Jan; 38(1):223-5. PubMed ID: 201375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On plasmocytoma--oncogenesis of mice. II. Differential ultracentrifugate which contains RNA virus-like particles from HIPA tumor inducing a plasmocytoid neoplasia in BALB-c mice.
    Pedio G; Grieshaber E; Rüttner JR
    Pathol Microbiol (Basel); 1968; 32(5):241-53. PubMed ID: 5742172
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumour cell-tumour cell emperipolesis studied by transmission electron microscopy.
    Chemnitz J; Bichel P
    Exp Cell Res; 1973 Dec; 82(2):319-24. PubMed ID: 4128812
    [No Abstract]   [Full Text] [Related]  

  • 13. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane.
    Byrd LG; McDonald AH; Gold LG; Potter M
    J Immunol; 1991 Nov; 147(10):3632-7. PubMed ID: 1682379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The allogeneic effect on tumor growth. II. Suppression of both ascitic and solid MOPC 315 plasmacytoma by the graft-vs-host reaction, with pathologic correlation.
    Osborne DP; Katz DH
    J Immunol; 1977 Apr; 118(4):1449-55. PubMed ID: 15035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the induction of tumorspecific T suppressor lymphocytes among the peritoneal exudate cells in histocompatible BALB/cAnPt and BALB/cJ mouse sublines.
    Lügering N; Kölsch E
    Immunobiology; 1991 Dec; 184(1):106-10. PubMed ID: 1839294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor antigens as inappropriately expressed normal alloantigens.
    Russell JH; Ginns LC; Terres G; Eisen HN
    J Immunol; 1979 Mar; 122(3):912-9. PubMed ID: 87420
    [No Abstract]   [Full Text] [Related]  

  • 17. A mathematical model for the quantitation of tumor and antibody-forming cell populations within an animal's body.
    Hiramoto RN; Ghanta VK; McGhee JR; Hamlin NM
    J Immunol; 1973 Nov; 111(5):1546-53. PubMed ID: 4583078
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
    Rouse BT; Röllinghoff M; Warner NL
    Eur J Immunol; 1973 Apr; 3(4):218-24. PubMed ID: 4541468
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo studies of a 2,4,6-trinitrophenyl (TNP)-binding immunoglobulin A (IgA) lymphoma isolated from MOPC-315, a TNP-binding IgA plasmacytoma of BALB/c mice.
    Gebel HM; Autry JR; Rohrer JW; Lynch RG
    J Natl Cancer Inst; 1979 Jan; 62(1):201-11. PubMed ID: 281574
    [No Abstract]   [Full Text] [Related]  

  • 20. [T x B hybrid clones capable of inhibiting the development of leukosis in vivo].
    Petrov RV; Sidorovich IG; Ignat'eva GA; Fuks BB
    Dokl Akad Nauk SSSR; 1983; 269(2):504-8. PubMed ID: 6602039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.